Product Liability: When Bad Things Happen to Good Companies
Guidant's problems with its ICD business, coming in the midst of its merger negotiations with Johnson & Johnson, highlighted the impact that product recalls and problems can have for companies. Generally speaking, product liability is becoming a bigger issue for medical device companies as consumers grow more skeptical that the government is protecting their interests where product safety is concerned.
You may also be interested in...
There was probably no group more relieved than the makers of implantable cardioverter defibrillators (ICDs) to see the Centers for Medicaid and Medicare Services (CMS) in August drastically modify its proposal to slash hospital reimbursement. The change is as a result of effective lobbying from the medical device community as well as the hospital industry, and is welcome news to all high-end device makers.
To build a “reliable long-term domestic production” of medicines and related supplies and to “minimize potential shortages,” US President Donald Trump has signed a ‘Buy American’ executive order. However, the move has left industry wondering if it is a sustainable solution.
The head of the German group's pharma BD team tells Scrip that Bayer has created a system which allows it to move quickly when sealing partnerships, as seen with the KaNDy buy on 11 August.